Work

Supplementary Data from DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors

Year: 2023

Type: supplementary-materials

Abstract: Figures S1-S7, Table S1

DOI: 10.1158/2767-9764.24316863

Authors: Helena Folly-Kossi, Joshua D. Graves, Lidija A. Wilhelms Garan, Fang-Tsyr Lin, Weei-Chin Lin

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4387673554

Cites:

Cited by:

Related to: 10